Conduction of IPO has been planned with further entry to the Hong Kong Stock Exchange by 2025.
We guarantee our partners:
- Prompt establishment of modern high-tech product manufacturing, equipped with international standards;
- High quality products that have undergone three-factor verification before sales launch;
- Equally fast delivery for both large and small lots of products;
- Convenient individual conditions of cooperation;
We invite you to become our partner!
|Name||Koru Pharmaceuticals Co., Ltd|
|Turnover in 2018||7 million USD|
|Turnover in 2019||11 million USD|
|Work Geography||Over 80 countries|
|Number of Laboratories||4|
|Number of suppliers||220|
|Number of products||Over 200|
|Number of Logistics Warehouses||3|
Apply now and our manager will get in touch with you shortly.
* — must be filled in.